Trastuzumab for gastric cancer treatment – Authors' reply

1 Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376: 687–97. 2 Okines AFC, Cunningham D. Trastuzumab in gastric cancer. Eur J Cancer 2010; 46: 1939–59. 3 Munro AJ, Niblock PG. Cancer research in the global village. Lancet 2010; 376: 659–60. 4 Ma BBY, Hui EP, Mok TSK. Population-based diff erences in treatment outcome following anticancer drug therapies. Lancet Oncol 2010; 11: 75–84. 5 Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for fi rst-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008; 9: 215–21. Trastuzumab for gastric cancer treatment